Sign Up to like & get
recommendations!
1
Published in 2017 at "Cancer Science"
DOI: 10.1111/cas.13253
Abstract: Trastuzumab emtansine (T‐DM1), an antibody–drug conjugate (ADC) consisting of human epidermal growth factor receptor 2 (HER2)‐targeted mAb trastuzumab linked to antimicrotubule agent mertansine (DM1), has been approved for the treatment of HER2‐positive metastatic breast cancer.…
read more here.
Keywords:
dm1;
n87 cells;
dm1 resistance;
resistance ... See more keywords